|1.||Chou, Tz-Chong: 6 articles (12/2015 - 01/2013)|
|2.||Lee, Wen-Sen: 6 articles (03/2013 - 01/2002)|
|3.||Ko, Chien-Hsin: 6 articles (01/2009 - 06/2003)|
|4.||Lin, Yi-Ruu: 6 articles (01/2009 - 06/2003)|
|5.||Chan, Ming-Huan: 6 articles (01/2009 - 06/2003)|
|6.||Chen, Hwei-Hsien: 6 articles (01/2009 - 06/2003)|
|7.||Chen, Yung-Hsiang: 5 articles (04/2014 - 01/2002)|
|8.||Chen, Tso-Hsiao: 3 articles (12/2015 - 01/2015)|
|9.||Lu, Sheng-Hua: 3 articles (12/2015 - 01/2013)|
|10.||Chen, Meng-Chuan: 3 articles (09/2015 - 05/2013)|
10/01/2015 - "Magnolol, the major active compound found in Magnolia officinalis has a wide range of clinical applications due to its anti-inflammation and anti-oxidation effects. "
01/01/2015 - "Magnolol, a compound extracted from the Chinese medicinal herb Magnolia officinalis, has been proved to exert multiple pharmacological effects, including anti-oxidant and anti-inflammation activities. "
05/12/2010 - "All these results revealed that magnolol is an effective antitumor agent and that its inhibitory effect is through the down-regulation of inflammatory iNOS and COX-2 gene expression in mouse skin, suggesting that magnolol is a novel functional agent capable of preventing inflammation-associated tumorigenesis."
02/01/2015 - "The purpose of this study was to investigate the protective effects of magnolol on inflammation in lipopolysaccharide (LPS)-induced mastitis mouse model in vivo and the mechanism of this protective effects in LPS-stimulated mouse mammary epithelial cells (MMECs) in vitro. "
12/28/2008 - "To investigate the protective effects of magnolol on sepsis-induced inflammation and intestinal dysmotility. "
01/01/2000 - "When one cecal puncture was performed, a moderately evolving type of sepsis was induced, and the survival rate of affected rats was significantly improved by pretreatment with 10(-7) g/kg magnolol. "
09/01/2010 - "The aim of this study was to evaluate the effects of magnolol on sepsis induced by intravenous (i.v.) administration of lipopolysaccharide (LPS; 10 mg/kg) in anaesthetized Wistar rats. "
08/01/2013 - "Our results suggest that magnolol treatment prevents sepsis-induced intestinal dysmotility by regulating SCF/c-kit and NO signaling to maintain functional ICCs."
08/01/2013 - "Magnolol pretreatment prevented the sepsis-induced increase in NO concentration, iNOS expression, and MDA concentration, and decrease in SOD activity in LPS-treated animals. "
08/01/2013 - "Magnolol pretreatment prevented sepsis-induced decreases in c-kit phosphorylation and SCF expression in LPS-treated animals. "
|3.||Parkinson Disease (Parkinson's Disease)
01/01/2012 - "These results suggest that magnolol has protective effects via an antioxidative mechanism in both in vivo and in vitro models of Parkinson's disease."
01/01/2012 - "Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease."
01/25/2012 - "After rats were intragastrically perfused with Anchanling, a Chinese medicine, mainly composed of magnolol, for 5 weeks, when compared with Parkinson's disease model rats, tyrosine hydroxylase expression was increased, α-synuclein and ubiquitin expression was decreased, substantia nigra cell apoptosis was reduced, and apomorphine-induced rotational behavior was improved. "
01/01/2013 - "Recent studies have also demonstrated that magnolol inhibits cell growth and induces the apoptosis of cancer cells. "
01/01/2011 - "The objectives of this investigation are to study the anticarcinogenic effects of magnolol on UVB-induced skin tumor development in SKH-1 mice, a model relevant to humans, and determine the possible role of apoptosis and cell cycle arrest involved in the skin tumor development. "
12/01/2002 - "The purpose of this study was to clarify the inhibitory mechanism of magnolol on the growth of tumor cells, and we expect that magnolol may have the ability to induce apoptosis in tumor cells. "
10/01/2015 - "In vivo, magnolol suppressed tumor growth and activated the same mechanisms as were activated in vitro. "
12/01/2013 - "Magnolol-induced inhibition of tumor growth in systemic malignancies."
10/01/2009 - "The protective efficacy of magnolol in hind limb ischemia-reperfusion injury."
06/15/2012 - "The present study investigated whether combined treatment of magnolol and HTS could provide further protection in mesenteric ischemia reperfusion injury. "
02/19/2015 - "Magnolol derivative 002C-3 protects brain against ischemia-reperfusion injury via inhibiting apoptosis and autophagy."
01/01/2012 - "Magnolol under low and moderate dosage possesses the ability to protect heart from ischemic/reperfusion injury, reduces atherosclerotic change, protects endothelial cell against apoptosis and inhibits neutrophil-endothelial adhesion. "
11/01/2002 - "Protective effect of magnolol on the small intestinal ischemia-reperfusion injury."
|2.||NF-kappa B (NF-kB)
|3.||Glutamic Acid (Glutamate)
|6.||Peroxisome Proliferator-Activated Receptors (PPAR)
|8.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
|2.||Chinese Traditional Medicine (Traditional Chinese Medicine)